POLY MEDICURE
|
|
| BOM : 531768     NSE : POLYMED     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 05,2026 |
|
Price(EOD): ₹ 1,419.80
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Medical Equipment/Supplies/Accessories |
| MCap: ₹ 14,396.77 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| POLY MEDICURE | 6.3% | -14.3% | -37.8% |
| LENSKART SOLUTIONS | -2.5% | 0.6% | NA |
| 3B BLACKBIO DX | 1.4% | -14.8% | -31.8% |
| LAXMI DENTAL | -0.2% | 7.1% | -40.3% |
| PREVEST DENPRO | -1% | -10.1% | -21.2% |
| NURECA | -1.4% | -16.9% | -9.1% |
FUNDAMENTAL ANALYSIS OF POLY MEDICURE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF POLY MEDICURE
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
45.68
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 315.05 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 4.63
P/B Calculated based on Book Value of Rs 3,106.17 Cr
[Latest Year - Mar2026 - Consolidated Results ] 7.67
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,875.26 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
49% 23% 26% |
SHARE PRICE MOMENTUM OF POLY MEDICURE
POLY MEDICURE vs SENSEX
DEBT OF POLY MEDICURE
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.06 0.11 0.11 0.09 |
0.06 0.12 0.12 0.1 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF POLY MEDICURE
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF POLY MEDICURE
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
8.28% -0.71% -12.94% -8.38% |
21.25% -7.69% -30.74% -29.28% |
| QtrlyTrend |
-4 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
POLY MEDICURE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 250 SMALLCAP INDEX | 0.2% | 0.6% | 0.7% |
| BSE HEALTHCARE | 0.2% | 3.5% | 9.8% |
| BSE 1000 | -0.7% | -1.3% | -1.9% |
| BSE 400 MIDSMALLCAP INDEX | -0.8% | 0.5% | 2.3% |
| BSE 500 | -0.8% | -1.6% | -2.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 500 | 0.5% | NA | NA |
| NIFTY MIDSMALL HEALTHCARE | 0.4% | 4.2% | 15.8% |
| NIFTY SMALLCAP 250 | 0.4% | 0.8% | 1.6% |
| NIFTY500 HEALTHCARE INDEX | 0.3% | 3.3% | NA |
| NIFTY 500 EQUAL WEIGHT | -0.2% | -0.1% | 1.3% |
You may also like the below Video Courses
FAQ about POLY MEDICURE
Is POLY MEDICURE good for long term investment?
As on Jun 05,2026, the Fundamentals of POLY MEDICURE look Strong and hence it may be good for long term investment! See Financial Performance of POLY MEDICURE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is POLY MEDICURE UnderValued or OverValued?
As on Jun 05,2026, POLY MEDICURE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of POLY MEDICURE ?
As on Jun 05,2026, the Intrinsic Value of POLY MEDICURE is Rs. 1,124.68 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 951.86
Fair Value [Median EV / Sales Model] : Rs. 1,151.36
Fair Value [Median Price / Sales Model] : Rs. 1,124.68
Estimated Median Fair Value of POLY MEDICURE : Rs. 1,124.68
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is POLY MEDICURE trading at a Premium or Discount?
As on Jun 05,2026, POLY MEDICURE is trading at a Premium of 26% based on the estimates of Median Intrinsic Value!LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD